155 related articles for article (PubMed ID: 7985166)
1. [The suppression of the renin-angiotensin system during the treatment of cardiovascular diseases].
Eliseev OM
Ter Arkh; 1994; 66(8):80-3. PubMed ID: 7985166
[No Abstract] [Full Text] [Related]
2. The renin angiotensin system and cardiovascular disease: hope or hype?
Williams B
J Renin Angiotensin Aldosterone Syst; 2000 Jun; 1(2):142-6. PubMed ID: 11967805
[No Abstract] [Full Text] [Related]
3. [The renin-angiotensin system in hypertension and heart insufficiency: current aspects in the use of ACE inhibitors].
Greminger P; Vetter W
Schweiz Rundsch Med Prax; 1988 Jun; 77(24):673-9. PubMed ID: 3041532
[No Abstract] [Full Text] [Related]
4. Inhibition of the renin-angiotensin system, with particular reference to dual blockade treatment.
Andersen NH; Mogensen CE
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):146-52. PubMed ID: 11881115
[No Abstract] [Full Text] [Related]
5. Antihypertensive strategy based on angiotensin II receptor blockers: a new gateway to reduce risk in hypertension.
Tocci G; Sciarretta S; Facciolo C; Volpe M
Expert Rev Cardiovasc Ther; 2007 Jul; 5(4):767-76. PubMed ID: 17605654
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin receptor blockers and cardiovascular protection: are we ONTARGET?
Ram CV; Deedwania PC
Am J Cardiol; 2008 Nov; 102(9):1281-3. PubMed ID: 18940307
[No Abstract] [Full Text] [Related]
7. Inhibiting the renin-angiotensin system to prevent cardiovascular diseases: do we need a more comprehensive strategy?
Weber MA; Giles TD
Rev Cardiovasc Med; 2006; 7(2):45-54. PubMed ID: 16915123
[TBL] [Abstract][Full Text] [Related]
8. Effectively targetting the renin-angiotensin-aldosterone system in cardiovascular and renal disease: rationale for using angiotensin II receptor blockers in combination with angiotensin-converting enzyme inhibitors.
Weinberg MS; Weinberg AJ; Zappe DH
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):217-33. PubMed ID: 11881029
[No Abstract] [Full Text] [Related]
9. Future directions in cardiovascular pharmacology: examples from the Renin-Angiotensin system.
Diz DI
Mol Interv; 2008 Oct; 8(5):222-5. PubMed ID: 19015385
[No Abstract] [Full Text] [Related]
10. Renin-angiotensin system modulation for treatment and prevention of cardiovascular diseases: toward an optimal therapeutic strategy.
Giles TD
Rev Cardiovasc Med; 2007; 8 Suppl 2():S14-21. PubMed ID: 17401312
[TBL] [Abstract][Full Text] [Related]
11. Preventing and reversing target organ damage by treatment of the renin-angiotensin system.
Krakoff LR; Rajasekharaiah V
Mt Sinai J Med; 1998 Mar; 65(2):125-32. PubMed ID: 9520516
[No Abstract] [Full Text] [Related]
12. More evidence on blocking the renin-angiotensin-aldosterone system in cardiovascular disease and the long-term treatment of hypertension: data from recent clinical trials (CHARM, EUROPA, ValHEFT, HOPE-TOO and SYST-EUR2).
Lip GY; Beevers DG
J Hum Hypertens; 2003 Nov; 17(11):747-50. PubMed ID: 14578913
[No Abstract] [Full Text] [Related]
13. [Vasopeptidase inhibitors. Clinical implications of a new class of drugs].
Quaschning T; Corti R; Ruschitzka FT; Noll G; Lüscher TF
Dtsch Med Wochenschr; 2000 Apr; 125(16):499-503. PubMed ID: 10819011
[No Abstract] [Full Text] [Related]
14. New opportunities in cardiovascular patient management: a survey of clinical data on the combination of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Weber MA
Am J Cardiol; 2007 Aug; 100(3A):45J-52J. PubMed ID: 17666198
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin receptor blockers: novel role in high-risk patients.
Javed U; Deedwania PC
Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
[TBL] [Abstract][Full Text] [Related]
16. [Prospective trends in the study of the therapeutic action of angiotensin-converting enzyme inhibitors in cardiovascular diseases].
Novikova LS; Arabidze GG
Ter Arkh; 1990; 62(1):118-23. PubMed ID: 2159193
[No Abstract] [Full Text] [Related]
17. [ACE-inhibitors in renal protection].
Barna I
Orv Hetil; 2006 Jun; 147(22):1019-23. PubMed ID: 16913091
[TBL] [Abstract][Full Text] [Related]
18. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
Burnier M
Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
[TBL] [Abstract][Full Text] [Related]
19. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
20. [Renin-angiotensin system modulation: instructions for use].
Bellis A; Rozza F; Crispo S; Trimarco B
G Ital Cardiol (Rome); 2008 Feb; 9(2):79-89. PubMed ID: 18383770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]